Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study.
Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study.
复制标题
DOI:
10.1186/s12933-023-02086-x
复制
发表时间:
2023-12-20
影响因子:
9.3
通讯作者:
中科院分区:
文献类型:
--
作者:
Primary aldosteronism (PA) is an adrenal disorder of autonomous aldosterone secretion which promotes arterial injury. We aimed to explore whether PA is causally associated with lower-extremity arterial disease (LEAD). We included 39,713 patients with diabetes and 419,312 participants without diabetes from UK Biobank. We derived a polygenic risk score (PRS) for PA based on previous genome-wide association studies (GWAS). Outcomes included LEAD and LEAD related gangrene or amputation. We conducted a two-sample Mendelian randomization analysis for PA and outcomes to explore their potential causal relationship. In whole population, individuals with a higher PA PRS had an increased risk of LEAD. Among patients with diabetes, compared to the subjects in the first tertile of PA PRS, subjects in the third tertile showed a 1.24-fold higher risk of LEAD (OR 1.24, 95% CI 1.03–1.49) and a 2.09-fold higher risk of gangrene (OR 2.09, 95% CI 1.27–3.44), and 1.72-fold higher risk of amputation (OR 1.72, 95% CI 1.10–2.67). Among subjects without diabetes, there was no significant association between PA PRS and LEAD, gangrene or amputation. Two-sample Mendelian randomization analysis indicated that genetically predictors of PA was significantly associated with higher risks of LEAD and gangrene (inverse variance weighted OR 1.20 [95% CI 1.08–1.34]) for LEAD, 1.48 [95% CI 1.28–1.70] for gangrene), with no evidence of significant heterogeneity or directional pleiotropy. Primary aldosteronism is genetically and causally associated with higher risks of LEAD and gangrene, especially among patients with diabetes. Targeting on the autonomous aldosterone secretion may prevent LEAD progression. The online version contains supplementary material available at 10.1186/s12933-023-02086-x.
登录
查看更多内容
影响因子:
16.6
作者:
通讯作者:
--
影响因子:
5.4
作者:
Hu, Jinbo;Shen, Hang;Huo, Peiqi;Yang, Jun;Fuller, Peter J.;Wang, Kanran;Yang, Yi;Ma, Linqiang;Cheng, Qingfeng;Gong, Lilin;He, Wenwen;Luo, Ting;Mei, Mei;Wang, Yue;Du, Zhipeng;Luo, Rong;Cai, Jun;Li, Qifu;Song, Ying;Yang, Shumin
通讯作者:
Yang, Shumin
影响因子:
39.3
作者:
Schäfer N;Lohmann C;Winnik S;van Tits LJ;Miranda MX;Vergopoulos A;Ruschitzka F;Nussberger J;Berger S;Lüscher TF;Verrey F;Matter CM
通讯作者:
Matter CM
DOI:
10.1097/ede.0000000000000559
发表时间:
2017-01
期刊:
Epidemiology (Cambridge, Mass.)
影响因子:
--
作者:
Burgess S;Bowden J;Fall T;Ingelsson E;Thompson SG
通讯作者:
Thompson SG
影响因子:
5.8
作者:
Funder, John W.;Carey, Robert M.;Young, William F., Jr.
通讯作者:
Young, William F., Jr.